LOS ANGELES--(BUSINESS WIRE)-- Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced ...
Vermont is better when we’re all informed. Join 30,000+ neighbors who start their day with local news that matters. Jack Glaser with a picture of his father and MBF Bioscience co-founder Edmund Glaser ...
Arizona's bioscience sector has a long way to go before it ranks in the top 10 states for federal research funding. Bioscience is not easy to explain and the sector could do a better job at ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
Indiana University is teaming up with Indiana Biosciences Research Center to create what they are calling a ā€œjoint center of excellenceā€ to develop better personalized care for patients with diabetes, ...
Our researchers aim to illuminate the underlying causes of disease, devise solutions and bring new treatments to communities. They're working to transform approaches to modern health care, leading to ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior leadership will parti ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The HonorHealth Research ...
The leadership team at the Lundquist Institute for Biomedical Innovation. (Photo by Thomas Wasper) Since its founding 74 years ago, the Lundquist Institute for Biomedical Innovation at Harbor-UCLA ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that its external research ...